Standard of care
Standard of care is an intervention with 1,213 clinical trials. Currently 259 active trials ongoing. Historical success rate of 84.3%.
Success Metrics
Based on 587 completed trials
Phase Distribution
Phase Distribution
48
Early Stage
178
Mid Stage
207
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.0%
587 of 762 finished
23.0%
175 ended early
259
trials recruiting
1,213
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Chronic Hepatitis B Virus Infection in Zambia
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Health-Related Social Needs Food Boxes Delivery Program
Reduce Inefficiencies in Management of Spasticity
Providing Oxygen During Intubation in the NICU Trial
Clinical Trials (1,213)
Chronic Hepatitis B Virus Infection in Zambia
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Health-Related Social Needs Food Boxes Delivery Program
Reduce Inefficiencies in Management of Spasticity
Providing Oxygen During Intubation in the NICU Trial
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Time-Restricted Eating for Type II Diabetes: TRE-T2D
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Real-world HCM-cohort Trial
Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Perioperative Steroid Dosing on the APR in AIS
The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients
Domestic Violence Enhanced Perinatal Care Program in China
Better Birth Outcomes Through Technology, Education, and Reporting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 1,213